Successes and challenges of China's health care reform: a four-decade perspective spanning 1985-2023.
Jakovljevic M, Chang H, Pan J, Guo C, Hui J, Hu H, Grujic D, Li Z, Shi L.
Jakovljevic M, et al.
Cost Eff Resour Alloc. 2023 Aug 30;21(1):59. doi: 10.1186/s12962-023-00461-9.
Cost Eff Resour Alloc. 2023.
PMID: 37649062
Free PMC article.
Review.
In terms of health sector this means that global demand and supply of medical goods, services and pharmaceuticals remains largely driven by Chinese domestic developments. Furthermore, Chinese domestic manufacturing and sales of decent quality medical devices and ser …
In terms of health sector this means that global demand and supply of medical goods, services and pharmaceuticals remains largely dri …